# Multicenter, Observational, Descriptive Study of the Diagnosis, Course and Treatment of Patients With SLE in Routine Practice in Kazakhstan: a Registry Study With Retrospective and Prospective Components.

> **NCT06899633** · — · ACTIVE_NOT_RECRUITING · sponsor: **AstraZeneca** · enrollment: 509 (actual)

## Conditions studied

- Description of SLE Activity in Patients in Routine Practice in the Republic of Kazakhstan
- Description of the Course of SLE in Patients in the Republic of Kazakhstan
- Description of Methods and Approaches to the Treatment of Patients With SLE in the Republic of Kazakhstan

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06899633
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-05-15
- **Primary completion:** 2027-02-28
- **Final completion:** 2027-02-28
- **Target enrollment:** 509 (ACTUAL)
- **Last updated:** 2026-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06899633

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06899633, "Multicenter, Observational, Descriptive Study of the Diagnosis, Course and Treatment of Patients With SLE in Routine Practice in Kazakhstan: a Registry Study With Retrospective and Prospective Components.". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT06899633. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*